MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 28, 2025. “We had good sales growth in our Global Distribution Group this quarter while experiencing lower margins in the U.S. versus the prior year primarily resulting from lower glove pricing as well as time-limited targeted sales initiatives. We are pleased
Related Questions
Are the time‑limited targeted sales initiatives a one‑off boost or an ongoing revenue driver?
How does Henry Schein's Q2 performance compare to its main competitors in the dental and medical supply space?
How might inventory levels and cash conversion cycles evolve given the recent sales trends?
Is the sales growth in the Global Distribution Group sustainable in the coming quarters?
What is the expected near‑term reaction of the stock price to this earnings release?
How will the lower U.S. margins affect Henry Schein's profitability and earnings guidance?
Will the margin compression in the U.S. lead to any adjustments in the company’s capital allocation or dividend policy?
What impact will reduced glove pricing have on future margin trends?
What guidance did management provide for the full‑year 2025 outlook?